Literature DB >> 22367737

Atmospheric oxygen inhibits growth and differentiation of marrow-derived mouse mesenchymal stem cells via a p53-dependent mechanism: implications for long-term culture expansion.

Siddaraju V Boregowda1, Veena Krishnappa, Jeremy W Chambers, Philip V Lograsso, Wen-Tzu Lai, Luis A Ortiz, Donald G Phinney.   

Abstract

Large scale expansion of human mesenchymal stem cells (MSCs) is routinely performed for clinical therapy. In contrast, developing protocols for large scale expansion of primary mouse MSCs has been more difficult due to unique aspects of rodent biology. Currently, established methods to isolate mouse MSCs select for rapidly dividing subpopulations that emerge from bone marrow cultures following long-term (months) expansion in atmospheric oxygen. Herein, we demonstrate that exposure to atmospheric oxygen rapidly induced p53, TOP2A, and BCL2-associated X protein (BAX) expression and mitochondrial reactive oxygen species (ROS) generation in primary mouse MSCs resulting in oxidative stress, reduced cell viability, and inhibition of cell proliferation. Alternatively, procurement and culture in 5% oxygen supported more prolific expansion of the CD45(-ve) /CD44(+ve) cell fraction in marrow, produced increased MSC yields following immunodepletion, and supported sustained MSC growth resulting in a 2,300-fold increase in cumulative cell yield by fourth passage. MSCs cultured in 5% oxygen also exhibited enhanced trilineage differentiation. The oxygen-induced stress response was dependent upon p53 since siRNA-mediated knockdown of p53 in wild-type cells or exposure of p53(-/-) MSCs to atmospheric oxygen failed to induce ROS generation, reduce viability, or arrest cell growth. These data indicate that long-term culture expansion of mouse MSCs in atmospheric oxygen selects for clones with absent or impaired p53 function, which allows cells to escape oxygen-induced growth inhibition. In contrast, expansion in 5% oxygen generates large numbers of primary mouse MSCs that retain sensitivity to atmospheric oxygen, and therefore a functional p53 protein, even after long-term expansion in vitro.
Copyright © 2012 AlphaMed Press.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22367737      PMCID: PMC3683654          DOI: 10.1002/stem.1069

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  50 in total

1.  Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate.

Authors:  C M Digirolamo; D Stokes; D Colter; D G Phinney; R Class; D J Prockop
Journal:  Br J Haematol       Date:  1999-11       Impact factor: 6.998

2.  Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models.

Authors:  D C Chow; L A Wenning; W M Miller; E T Papoutsakis
Journal:  Biophys J       Date:  2001-08       Impact factor: 4.033

Review 3.  Prospective isolation of stromal progenitor cells from mouse BM.

Authors:  B Short; N Brouard; R Driessen; P J Simmons
Journal:  Cytotherapy       Date:  2001       Impact factor: 5.414

4.  Oxygen accelerates the accumulation of mutations during the senescence and immortalization of murine cells in culture.

Authors:  Rita A Busuttil; Miguel Rubio; Martijn E T Dollé; Judith Campisi; Jan Vijg
Journal:  Aging Cell       Date:  2003-12       Impact factor: 9.304

5.  Isolation of mouse marrow mesenchymal progenitors by a novel and reliable method.

Authors:  Shengkun Sun; Zikuan Guo; Xuren Xiao; Bing Liu; Xiaodan Liu; Pei-Hsien Tang; Ning Mao
Journal:  Stem Cells       Date:  2003       Impact factor: 6.277

6.  Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection.

Authors:  Melody Baddoo; Katy Hill; Robin Wilkinson; Dina Gaupp; Catherine Hughes; Gene C Kopen; Donald G Phinney
Journal:  J Cell Biochem       Date:  2003-08-15       Impact factor: 4.429

7.  Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo.

Authors:  A Al-Khaldi; N Eliopoulos; D Martineau; L Lejeune; K Lachapelle; J Galipeau
Journal:  Gene Ther       Date:  2003-04       Impact factor: 5.250

Review 8.  The ARF-p53 senescence pathway in mouse and human cells.

Authors:  R Wadhwa; T Sugihara; K Taira; S C Kaul
Journal:  Histol Histopathol       Date:  2004-01       Impact factor: 2.303

9.  Regulation of myeloid and lymphoid development of hematopoietic stem cells by bone marrow stromal cells.

Authors:  M Obinata; R Okuyama; K I Matsuda; M Koguma; N Yanai
Journal:  Leuk Lymphoma       Date:  1998-03

10.  Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization.

Authors:  Lindolfo da Silva Meirelles; Nance Beyer Nardi
Journal:  Br J Haematol       Date:  2003-11       Impact factor: 6.998

View more
  46 in total

1.  Chromatographically isolated CD63+CD81+ extracellular vesicles from mesenchymal stromal cells rescue cognitive impairments after TBI.

Authors:  Dong-ki Kim; Hidetaka Nishida; Su Yeon An; Ashok K Shetty; Thomas J Bartosh; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-22       Impact factor: 11.205

Review 2.  Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.

Authors:  Daniel J Weiss
Journal:  Ann Am Thorac Soc       Date:  2013-10

Review 3.  Mesenchymal stem cells as cellular vectors for pediatric neurological disorders.

Authors:  Donald G Phinney; Iryna A Isakova
Journal:  Brain Res       Date:  2014-05-22       Impact factor: 3.252

4.  Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis.

Authors:  Chider Chen; Dandan Wang; Alireza Moshaverinia; Dawei Liu; Xiaoxing Kou; Wenjing Yu; Ruili Yang; Lingyun Sun; Songtao Shi
Journal:  Cell Res       Date:  2017-01-20       Impact factor: 25.617

Review 5.  Concise review: optimizing expansion of bone marrow mesenchymal stem/stromal cells for clinical applications.

Authors:  Allison I Hoch; J Kent Leach
Journal:  Stem Cells Transl Med       Date:  2014-03-28       Impact factor: 6.940

6.  Should publications on mesenchymal stem/progenitor cells include in-process data on the preparation of the cells?

Authors:  Roxanne L Reger; Darwin J Prockop
Journal:  Stem Cells Transl Med       Date:  2014-04-01       Impact factor: 6.940

7.  Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression.

Authors:  Robert M Hughes; Brian W Simons; Hamda Khan; Rebecca Miller; Valentina Kugler; Samantha Torquato; Debebe Theodros; Michael C Haffner; Tamara Lotan; Jessie Huang; Elai Davicioni; Steven S An; Ryan C Riddle; Daniel L J Thorek; Isla P Garraway; Elana J Fertig; John T Isaacs; W Nathaniel Brennen; Ben H Park; Paula J Hurley
Journal:  Cancer Res       Date:  2019-05-23       Impact factor: 12.701

8.  Intra-articular delivery of purified mesenchymal stem cells from C57BL/6 or MRL/MpJ superhealer mice prevents posttraumatic arthritis.

Authors:  Brian O Diekman; Chia-Lung Wu; Craig R Louer; Bridgette D Furman; Janet L Huebner; Virginia B Kraus; Steven A Olson; Farshid Guilak
Journal:  Cell Transplant       Date:  2012-08-10       Impact factor: 4.064

9.  Isolation, selection and culture methods to enhance clonogenicity of mouse bone marrow derived mesenchymal stromal cell precursors.

Authors:  Claas Baustian; Shirley Hanley; Rhodri Ceredig
Journal:  Stem Cell Res Ther       Date:  2015-08-25       Impact factor: 6.832

10.  Tumor Formation of Adult Stem Cell Transplants in Rodent Arthritic Joints.

Authors:  Fanny Chapelin; Aman Khurana; Mohammad Moneeb; Florette K Gray Hazard; Chun Fai Ray Chan; Hossein Nejadnik; Dita Gratzinger; Solomon Messing; Jason Erdmann; Amitabh Gaur; Heike E Daldrup-Link
Journal:  Mol Imaging Biol       Date:  2019-02       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.